Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,708
Closed -$1.87M 782
2025
Q4
$1.87M Sell
5,708
-4,116
-42% -$1.31M 0.06% 252
2025
Q3
$2.77M Buy
9,824
+4,105
+72% +$1.19M 0.08% 202
2025
Q2
$1.6M Buy
5,719
+39
+0.7% +$11K 0.04% 264
2025
Q1
$1.77M Buy
5,680
+3,469
+157% +$1.02M 0.09% 179
2024
Q4
$576K Buy
+2,211
New +$656K 0.03% 314

Other funds holding AMGN

SIG Brokerage's AMGN Position: Q1 2026 in Review

SIG Brokerage sold out of Amgen (AMGN) in Q1 2026, closing a stake of 5,708 shares — an estimated $1.87M sold.

SIG Brokerage first reported a position in AMGN in Q4 2024 and held it in 5 quarters. The position peaked at $2.77M in Q3 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • SIG Brokerage reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • SIG Brokerage sold 5,708 Amgen shares in Q1 2026, an estimated $1.87M.
  • SIG Brokerage first reported a position in Amgen in Q4 2024 and held it in 5 quarters.
  • SIG Brokerage's Amgen position peaked at $2.77M in Q3 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.